NOTCH2NLC Repeat Expansions in Parkinsonian Disorders: Clinical and Neuroimaging Characteristics. [PDF]
Chiang HL +7 more
europepmc +1 more source
Moving beyond the hospital: in-depth characterization of daily-life mobility in patients with atypical Parkinsonian disorders. [PDF]
Sidoroff V +23 more
europepmc +1 more source
Serious Illness Conversation in the Care of Atypical Parkinsonian Disorders: A Practical Guide for Neurology Clinicians. [PDF]
Bruno MK +7 more
europepmc +1 more source
Cell Death in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets
Regulated cell death pathways, including apoptosis, necroptosis, pyroptosis, ferroptosis, and autophagy‐dependent cell death, interact with mitochondrial dysfunction, proteostasis failure, lysosomal stress, glial remodeling, and neuroinflammation across major neurodegenerative diseases.
Tianjiao Li +3 more
wiley +1 more source
Corticotropin-releasing hormone as a candidate biomarker for parkinsonian disorders. [PDF]
Fernandes Gomes B +9 more
europepmc +1 more source
Abstract Aim Delirium, a serious neuropsychiatric hospitalization complication, is a manifestation of underlying neurocognitive vulnerability rather than an acute event. In Japan, a nationwide medical policy mandates early hospital‐wide delirium risk screening to evaluate predefined risk factors in inpatient populations.
Megumi Matsuda +12 more
wiley +1 more source
Integrating tele-palliative care for atypical Parkinsonian disorders: Lessons learned from a pilot program. [PDF]
Afshari M +7 more
europepmc +1 more source
The κ opioid receptor (κ receptor, KOR) is a G protein‐coupled receptor with well established roles in analgesia and immune modulation. Although historically studied primarily in the central nervous system (CNS), growing evidence indicates that κ signalling in peripheral tissues plays an important role in regulating pain, inflammation and immune ...
Rumsha Khan +3 more
wiley +1 more source
We present a set of multifunctional tacrine derivatives, designed with the CADMA‐Chem protocol, aimed for Alzheimer and Parkinson diseases. Of the tacrines designed, TAC‐674 and TAC‐678 are the best candidates to act as multifunctional antioxidants and neuroprotectors for Alzheimer and Parkinson diseases, respectively.
Eugenia Dzib +3 more
wiley +1 more source
A General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders: A Consensus Statement. [PDF]
Bruno MK +17 more
europepmc +1 more source

